Cyril a happy man as Biovac, Pfizer join forces
Speaking in his capacity as African Union Champion on COVID-19, Ramaphosa said that this agreement will contribute significantly to health security and sustainability on the continent.
“Today’s agreement will contribute significantly to health security and sustainability on our continent, which currently has the least access to vaccinations in the world,” Ramaphosa said.
The Pfizer COVID-19 vaccine will be produced by the Biovac Institute in Cape Town. Biovac is a vaccine producer and public-private partnership between the South African government and the private pharmaceutical sector.
“The partnership between Biovac and Pfizer is a breakthrough in our effort to overcome global vaccine inequity. The protection of Africans is a necessary and critical contribution to the protection of humanity as a whole. This partnership demonstrates what we can achieve when the state and private sectors craft a shared vision and pool resources for the greater good of society,” added Ramaphosa.
Biovac will immediately embark on technological transfer activities that includes on-site development and equipment installation for the production of the Pfizer-BioNtech COVID-19 vaccines. The facility will be brought into the Pfizer-BioNtech supply chain by the end of 2021. Biovac will obtain the drug substances from BioNTech’s facilities in Germany.
The African Union Champion on #COVID19, President Cyril Ramaphosa, has welcomed the announcement that the #Pfizer COVID-19 vaccine will be produced in Cape Town by the @biovac_inst https://t.co/Y2eww5yHlT pic.twitter.com/ZuKCiqcpj0
— @SAgovnews (@SAgovnews) July 21, 2021
Cyril recognises collaboration
At full operational capacity, the annual COVID-19 vaccine production will aim for 100 million finished doses annually, which some experts believe is little optimistic. All doses will exclusively be distributed within the 55 African Union member states. Biovac’s expansion in production and acquisition of specialised equipment related to mRNA technology entails an investment of R200-million in the coming six months.
“This collaboration recognises the talent and technology that exists on our continent that can be harnessed within our irreversible march of sustainable and inclusive development,” Ramaphosa said.
President Ramaphosa wishes the partnership well and urges people throughout the continent to play their part by making themselves available to be vaccinated.
“The more we roll up our sleeves to receive our jabs, the safer we will be as individuals, families and communities. The safer we are, the more secure our future as a continent on the rise will be.”
Mr Strive Masiyiwa, African Union Special Envoy on COVID-19 and member of the African Vaccine Acquisition Task Team, joined President Ramaphosa in welcoming the Biovac-Pfizer initiative.
Masiyiwa said: “The only way to guarantee Africa’s access to vaccines now and in the future is through this type of strategic manufacturing partnerships, which we welcome greatly.” – Health-e News
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Cyril a happy man as Biovac, Pfizer join forces
by Nompilo Gwala, Health-e News
July 26, 2021